Overview
Exosomes are naturally occurring extracellular vesicles gaining attention as potential carriers for therapeutic molecules. Their biocompatibility, cargo-loading capabilities, and potential to interact with specific cell types make them promising candidates for next-generation drug delivery systems.
Advances in drug-loading techniques, surface engineering, and targeting strategies are expanding their potential applications in oncology, neurological disorders, and other therapeutic areas. However, challenges involving targeted delivery, manufacturing consistency, scalability, and clinical validation remain important considerations for translating exosome technologies into practical treatments.
This whitepaper includes details of drug-loading and surface-engineering technologies, targeting strategies, recent commercial trends, and clinical trials shaping exosome-based therapeutics.
Key Insights You’ll Gain
How Stellarix Can Help
Stellarix helps life sciences organizations in evaluating cutting-edge drug delivery technologies and identifying high-value opportunities for therapeutic innovation. Through technology scouting, competitive intelligence, patent analysis, and innovation strategy, we enable stakeholders to evaluate exosome engineering approaches, track R&D activity, and identify potential collaboration opportunities across the continuously evolving biologics landscape.
